Show simple item record

dc.contributor.authorMüller, Kai Ivar
dc.contributor.authorAlstadhaug, Karl Bjørnar
dc.contributor.authorBekkelund, Svein Ivar
dc.date.accessioned2018-08-15T12:18:27Z
dc.date.available2018-08-15T12:18:27Z
dc.date.issued2017-07-11
dc.description.abstract<p><i>Objective</i>: To evaluate long-term treatment efficacy and safety of one-time telemedicine consultations for nonacute headaches.</p> <p><i>Methods</i>: We randomized, allocated, and consulted nonacute headache patients via telemedicine (n = 200) or in a traditional manner (n = 202) in a noninferiority trial. Efficacy endpoints, assessed by questionnaires at 3 and 12 months, included change from baseline in Headache Impact Test–6 (HIT-6) (primary endpoint) and pain intensity (visual analogue scale [VAS]) (secondary endpoint). The primary safety endpoint, assessed via patient records, was presence of secondary headache within 12 months after consultation.</p> <p><i>Results</i>: We found no differences between telemedicine and traditional consultations in HIT-6 (p = 0.84) or VAS (p = 0.64) over 3 periods. The absolute difference in HIT-6 from baseline was 0.3 (95% confidence interval [CI] −1.26 to 1.82, p = 0.72) at 3 months and 0.2 (95% CI −1.98 to 1.58, p = 0.83) at 12 months. The absolute change in VAS was 0.4 (95% CI −0.93 to 0.22, p = 0.23) after 3 months and 0.3 (95% CI −0.94 to 0.29, p = 0.30) at 12 months. We found one secondary headache in each group at 12 months. The estimated number of consultations needed to miss one secondary headache with the use of telemedicine was 20,200.</p> <p><i>Conclusion</i>: Telemedicine consultation for nonacute headache is as efficient and safe as a traditional consultation.en_US
dc.description.sponsorshipThe Northern Norway Regional Health Authority (Helse Nord RHF)en_US
dc.descriptionSource at <a href=https://doi.org/10.1212/WNL.0000000000004085> https://doi.org/10.1212/WNL.0000000000004085</a>.en_US
dc.identifier.citationMüller, K.I., Alstadhaug, K.B. & Bekkelund, S.I. (2017). A randomized trial of telemedicine efficacy and safety for nonacute headaches. Neurology, 89(2), 153-162. https://doi.org/10.1212/WNL.0000000000004085en_US
dc.identifier.cristinIDFRIDAID 1501533
dc.identifier.doi10.1212/WNL.0000000000004085
dc.identifier.issn0028-3878
dc.identifier.issn1526-632X
dc.identifier.urihttps://hdl.handle.net/10037/13408
dc.language.isoengen_US
dc.publisherAmerican Academy of Neurologyen_US
dc.relation.journalNeurology
dc.rights.accessRightsopenAccessen_US
dc.subjectVDP::Medisinske Fag: 700::Klinisk medisinske fag: 750::Nevrologi: 752en_US
dc.subjectVDP::Medical disciplines: 700::Clinical medical disciplines: 750::Neurology: 752en_US
dc.titleA randomized trial of telemedicine efficacy and safety for nonacute headachesen_US
dc.typeJournal articleen_US
dc.typeTidsskriftartikkelen_US
dc.typePeer revieweden_US


File(s) in this item

Thumbnail

This item appears in the following collection(s)

Show simple item record